Labisia pumila var. alata reduces bacterial load by inducing uroepithelial cell apoptosis.
Fazliana. Mansor M; Ramos. Nubia L NL; Lüthje. Petra P; Sekikubo. Musa M; Holm. Asa A; Wan Nazaimoon. W M WM; Brauner. Annelie A
Key Findings
- LPva triggers apoptosis in bladder epithelial cells (T24 and 5637).
- Apoptosis is linked to higher caveolin‑1 and lower β1‑integrin expression.
- LPva does not have direct antibacterial activity, nor does it alter LL‑37 or HBD‑2 levels.
- Intracellular uropathogenic E. coli (UPEC) counts drop significantly after LPva treatment.
Practical Outcomes
- For self‑experimenters, the herb may be worth exploring as a supportive measure to limit recurrent urinary‑tract infections by targeting infected cells rather than killing bacteria outright. However, because the data are from cell‑culture experiments only, no dosage, safety, or efficacy guidance for humans is available yet. Caution and further research are needed before incorporating LPva into a personal health protocol.
Summary
A Malaysian herb called Labisia pumila var. alata (LPva) can make bladder cells die in a controlled way, which helps lower the number of urinary‑tract bacteria that hide inside those cells. It doesn't kill the bacteria directly and doesn't change levels of the natural antimicrobial peptide LL‑37, but by prompting the infected cells to undergo apoptosis it reduces bacterial invasion.
Abstract
Labisia pumila var. alata (LPva) is a traditional medicinal herb used by Malaysian women to treat many ailments of the genitourinary tract. Its phytoestrogenic properties suggest potential to prevent recurrent urinary tract infection (UTI) in women post menopause. The aim of this study was therefore to investigate the mechanisms of action of LPva in an in vitro model of UTI. Bladder epithelial cell lines T24 and 5637 and uropathogenic Escherichia coli (UPEC) strain CFT073 were used to model uroepithelial infection. The ability of LPva to induce programmed cell death was tested using the Annexin-V-FLUOS and TUNEL assays. Expression of caveolin-1, β1 integrin and antimicrobial peptides HBD-2 and LL-37 in response to LPva treatment and/or infection, was assessed using RT real-time PCR. Effects on protein expression were confirmed by Western blot analysis. Sensitivity and yeast agglutination assays were employed to determine if LPva had antimicrobial activities and/or interacted with type 1 fimbriae, respectively. Finally, bacterial adherence and invasion to cells treated with LPva was examined. LPva induced uroepithelial apoptosis which was coupled with upregulated expression of caveolin-1 and downregulation of β1 integrin. LPva did not exhibit direct antimicrobial properties and did not influence antimicrobial peptide levels in cells. Additionally, LPva did not interact with type 1 fimbriae and did not affect adherence in comparison to non-treated control cells. However, LPva significantly reduced the number of intracellular UPEC in bladder epithelial cells. Our findings suggest that LPva has beneficial applications against UPEC infection due to its ability to induce programmed cell death and reduce bacterial invasion of the uroepithelium.
Study Information
pubmed
2011
2011-04-15T00:00:00.000Z
10.1016/j.jep.2011.04.018
24
29